MKI67 and breast cancer: In summary, our study demonstrated comparable interobserver agreement in the quantitative assessment of HER2 and Ki-67 for breast cancer with optical and digital microscopy, as well as relatively high intermodality agreement, supporting the potential of digital microscopy for these tasks.